01 8AbbVie Corporation
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Brand Name : FETZIMA
Patent Number : 2514948
Filing Date : 2004-02-16
Strength per Unit : 20 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Brand Name : FETZIMA
Patent Number : 2514948
Filing Date : 2004-02-16
Strength per Unit : 40 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Brand Name : FETZIMA
Patent Number : 2514948
Filing Date : 2004-02-16
Strength per Unit : 80 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Brand Name : FETZIMA
Patent Number : 2514948
Filing Date : 2004-02-16
Strength per Unit : 120 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-02-16
Date Granted : 2013-04-02
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Brand Name : FETZIMA
Patent Number : 2779711
Filing Date : 2010-11-08
Strength per Unit : 20 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Brand Name : FETZIMA
Patent Number : 2779711
Filing Date : 2010-11-08
Strength per Unit : 40 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Brand Name : FETZIMA
Patent Number : 2779711
Filing Date : 2010-11-08
Strength per Unit : 80 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
Brand Name : FETZIMA
Patent Number : 2779711
Filing Date : 2010-11-08
Strength per Unit : 120 mg
Dosage Form : CAPSULE (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-11-08
Date Granted : 2016-11-01
LOOKING FOR A SUPPLIER?
